Skip to main content
editorial
. 2011 Jul 10;2(7):281–288. doi: 10.5306/wjco.v2.i7.281

Table 4.

Toxicities in trials comparing rituximab maintenance vs observation in follicular lymphoma

Reference No of. patients Grade 3-4 AE Neutropenia (grade 3-4) Grade 3-4 Infections
Haisworth et al[16]
62
9% vs 4%
2% vs 0%
0
Ghielmini et al[14] Martinelli et al[19]
185
28% vs 20%
18% vs 17%
NA
Hochster et al[17]
228
NA
3% vs 1%
1% vs 1%
Forstpointner et al[10]
105
NA
13% vs 6%
4% vs 3%
van Oers et al[6]
334
NA
10.8% vs 5.4%(P = 0.07)
9% vs 2.4% (P = 0.009)
Salles et al[18,23] 1018 23% vs 16% 4% vs 1% 4% vs 1%